Name: | Description: | Size: | Format: | |
---|---|---|---|---|
294.71 KB | Adobe PDF |
Advisor(s)
Abstract(s)
SARS-CoV-2 infection ranges from mild to severe presentations, according to the intensity of
the aberrant inflammatory response. Purinergic receptors dually control the inflammatory response:
while adenosine A2A receptors (A2ARs) are anti-inflammatory, ATP P2X7 receptors (P2X7Rs) exert
pro-inflammatory effects. The aim of this study was to assess if there were differences in allelic and
genotypic frequencies of a loss-of-function SNP of ADORA2A (rs2298383) and a gain-of-function
single nucleotide polymorphism (SNP) of P2RX7 (rs208294) in the severity of SARS-CoV-2-associated
infection. Fifty-five individuals were enrolled and categorized according to the severity of the
infection. Endpoint genotyping was performed in blood cells to screen for both SNPs. The TT
genotype (vs. CT + CC) and the T allele (vs. C allele) of P2RX7 SNP were found to be associated with
more severe forms of COVID-19, whereas the association between ADORA2A SNP and the severity of
infection was not significantly different. The T allele of P2RX7 SNP was more frequent in people with
more than one comorbidity and with cardiovascular conditions and was associated with colorectal
cancer. Our findings suggest a more prominent role of P2X7R rather than of A2AR polymorphisms in
SARS-CoV-2 infection, although larger population-based studies should be performed to validate
our conclusions.
Description
Keywords
Adenosine A2A receptor ATP P2X7 receptor COVID-19 SARS-CoV-2 Polymorphisms
Citation
LINDO, Jorge [et al.] (2024) - Genetic polymorphisms of P2RX7 but not of ADORA2A are associated with the severity of SARS-CoV-2 infection. International Journal of Molecular Sciences. 11:25, p.6135. DOI: https://doi.org/10.3390/ijms25116135
Publisher
MDPI